Qiagen N.V. (FRA:QIA)
Germany flag Germany · Delayed Price · Currency is EUR
42.21
+0.20 (0.49%)
Last updated: Jul 23, 2025

Qiagen Company Description

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories.

It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, such as assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing.

The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables, such as short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions.

It offers NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments; bioinformatics solutions; and custom laboratory and genomic services.

The company provides software-as-a-service. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers.

The company was founded in 1984 and is headquartered in Venlo, the Netherlands.

Qiagen N.V.
CountryNetherlands
Founded1984
IndustryLaboratory Analytical Instruments
Employees5,396
CEOThierry Bernard

Contact Details

Address:
Hulsterweg 82
Venlo, 5912 PL
Netherlands
Phone31 77 355 6600
Websiteqiagen.com

Stock Details

Ticker SymbolQIA
ExchangeFrankfurt Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyUSD
SIC Code3826

Key Executives

NamePosition
Thierry BernardChief Executive Officer
Roland SackersChief Financial Officer
Antonio SantosChief Operating Officer
John GilardiHead of Investor Relations